Combiwave SF 25mcg/125mcg Inhaler
By Combiwave SF
Rx
150mdi Inhaler in a Packet

Composition
Salmeterol(25mcg) + Fluticasone Propionate(125mcg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
September, 2025
About Combiwave SF 25mcg/125mcg Inhaler
Combiwave SF 25mcg/125mcg Inhaler is a medication that combines two medicines to help open the airways, making it easier to breathe. It is commonly used in the treatment of asthma, which causes symptoms like wheezing and shortness of breath, as well as chronic obstructive pulmonary disorder (COPD), a condition that blocks airflow to the lungs.
Your doctor will provide guidance on how frequently you should use the inhaler. While you may start to notice the effects of the medicine within a few days, it typically takes a few weeks to reach its maximum effectiveness. Consistent use is crucial for the medication to work optimally, even if you are not experiencing any symptoms at the time. Should you abruptly stop taking the medication, your asthma and COPD symptoms may worsen. It's important to note that Combiwave SF 25mcg/125mcg Inhaler is not meant to treat sudden asthma attacks; for such emergencies, a quick-relief inhaler (reliever) should be used.
Common side effects of this medication include nausea, vomiting, respiratory tract infections, fungal infections in the mouth, headaches, hoarseness of voice, sore throat, cough, musculoskeletal pain, and increased heart rate. If you experience any of these side effects, it is advisable not to discontinue the medication but to consult your doctor. To help reduce the occurrence of side effects, consider rinsing your mouth and throat with water or brushing your teeth following inhaler use. It should be noted that there are rare but serious side effects associated with this medication, which should be discussed with your healthcare provider.
Individuals who are pregnant or breastfeeding should seek advice from their doctor regarding the safety of using this medication. Additionally, individuals with kidney or liver diseases should inform their healthcare provider before starting treatment to ensure an appropriate dosage is prescribed. Overall, it is recommended to avoid triggers that can worsen asthma symptoms and refrain from smoking while using Combiwave SF 25mcg/125mcg Inhaler.
Benefits
Combiwave SF 25mcg/125mcg Inhaler offers numerous benefits in the treatment of chronic obstructive pulmonary disease (COPD) and asthma. For individuals with COPD, this medication helps keep the airways in the lungs open by relaxing the muscles surrounding them. By doing so, it facilitates the easy flow of air in and out of the lungs, thereby alleviating symptoms like chest tightness, shortness of breath, wheezing, and coughing. This leads to improved ease in carrying out daily activities. The effects of Combiwave SF 25mcg/125mcg Inhaler typically begin within a few minutes of use and can last for several hours, providing quick and effective relief. It is important to note that discontinuing the use of this medication should only be done under the guidance of a healthcare professional.
Moreover, for individuals with asthma, Combiwave SF 25mcg/125mcg Inhaler can be beneficial in preventing asthma attacks if taken prior to exercise or exposure to triggers such as house dust, pollen, pets, or cigarette smoke. By using this medication proactively, individuals can engage in physical activities more freely without the fear of experiencing symptoms like wheezing, coughing, and shortness of breath. This aspect of the medication allows individuals to lead a more unrestricted life, without the constant worry of encountering triggers that may exacerbate their asthma symptoms.
In summary, Combiwave SF 25mcg/125mcg Inhaler provides effective treatment and prevention of respiratory disorders like asthma and COPD. The combination of two active ingredients, Salmeterol and Fluticasone propionate, works synergistically to improve pulmonary function, relax muscles, widen airways, and reduce inflammation in the bronchial tubes. By addressing these key components, Combiwave SF 25mcg/125mcg Inhaler offers relief from symptoms like shortness of breath, chronic bronchitis, and other respiratory distress. This safe and efficient medication enables individuals to manage their conditions effectively and enhance their quality of life.
How to use the Combiwave SF 25mcg/125mcg Inhaler
To properly use Combiwave SF 25mcg/125mcg Inhaler, start by checking the label for directions. Shake the inhaler well before each use. Your doctor or nurse will demonstrate the correct technique for using the inhaler. Hold the inhaler upright and place the mouthpiece between your teeth, making sure not to bite down on it. As you breathe in through your mouth, press down on the top of the inhaler to release a puff of medication while continuing to inhale. Hold your breath for as long as comfortable before exhaling slowly. If another puff is needed, wait for a minute before repeating the process. Remember to rinse your mouth thoroughly with water and spit it out after using the inhaler to prevent any potential side effects. Close the mouthpiece with the cover to avoid dust or contamination. Follow the dosage instructions provided by your doctor and do not exceed the recommended dose of Combiwave SF 25mcg/125mcg Inhaler. Your doctor will determine the appropriate dose and duration of treatment based on your age, weight, and medical condition. If you have any questions or concerns about using the Nexhaler, be sure to consult your healthcare provider for guidance.
Uses of Combiwave SF 25mcg/125mcg Inhaler
The Combiwave SF 25mcg/125mcg Inhaler is commonly used for treating Chronic obstructive pulmonary disease (COPD) and Asthma. It is effective in managing asthma symptoms and severe cases of COPD. The inhaler is specifically designed to help with breathing difficulties associated with these conditions. It is an important tool in the treatment of respiratory diseases, providing relief and improving the quality of life for individuals living with COPD and asthma.
What conditions Combiwave SF 25mcg/125mcg Inhaler treats?
Asthma and Chronic obstructive pulmonary disease (COPD) are two main conditions that can affect breathing. Asthma causes the airways to narrow, swell, and produce extra mucus, making it harder to breathe. COPD is a group of lung diseases like emphysema and chronic bronchitis, where the airflow is blocked, leading to breathing difficulties. Emphysema causes shortness of breath, while chronic bronchitis is linked to inflammation in the bronchial tubes that carry air to the lungs.
Should you consult a doctor?
Before using Combiwave SF 25mcg/125mcg Inhaler, it is important to consult a doctor if you have certain conditions such as an aneurysm, overactive thyroid gland, planned surgery, stress, diabetes, low levels of potassium, poor adrenal gland function, or pheochromocytoma. Symptoms of low potassium levels can include muscle weakness, twitching, and abnormal heart rhythms. Poor adrenal gland function may show up as weakness, tiredness, headache, abdominal pain, weight loss, loss of appetite, dizziness, very low blood pressure, diarrhea, nausea, vomiting, or fits. Combiwave SF 25mcg/125mcg Inhaler is not recommended for children under 12 years old, so parents should consult their child's doctor for guidance. If you experience any of these conditions or symptoms, seeking medical advice is crucial before starting treatment with Combiwave SF 25mcg/125mcg Inhaler.
Side effects of Combiwave SF 25mcg/125mcg Inhaler
When taking Combiwave SF 25mcg/125mcg Inhaler, you may experience some side effects. Most side effects are usually mild and fade away as your body gets used to the medication. Common side effects include cough, upper respiratory tract infection, nasal inflammation, sinus inflammation, stomach discomfort, fungal infections in the mouth, voice changes, headaches, and dry mouth. Other potential side effects include low-grade fever, chest tightness, sinus pain, nausea, upset stomach, dizziness, nervousness, muscle and bone pain, sleep disturbances, vomiting, irregular heartbeat, and changes in voice quality. Some users may also encounter shaking or tremors, altered heartbeat rhythms, difficulty sleeping, dry mouth, throat irritation, rashes, oral thrush, sinus inflammation, rapid heartbeat, chest pain, muscle spasms, respiratory issues, diarrhea, indigestion, taste changes, dizziness, unusual dreams, agitation, itchy skin, high blood pressure, weakness, and swelling in extremities. If you experience severe side effects such as sudden swelling of the face, throat, or extremities, rash or itching all over the body, fainting, breathing difficulties, blurred vision, or sudden allergic reactions, it is crucial to discontinue use and seek immediate medical attention. Remember to consult your doctor if any side effects persist or cause concern.
Safety advice

liver
When using Combiwave SF 25mcg/125mcg Inhaler, it is important to note that no interactions related to liver issues have been found or established. However, caution should still be exercised when using this medication, especially if you have existing liver conditions or concerns. It is always advisable to consult with your doctor before starting Combiwave SF 25mcg/125mcg Inhaler to ensure it is safe for you, especially if you have any liver-related issues. Your doctor can provide proper guidance based on your individual health situation.

kidney
No interaction has been found or established with Combiwave SF 25mcg/125mcg Inhaler regarding kidney issues.

alcohol
It is not known if it is safe to drink alcohol while using Combiwave SF 25mcg/125mcg Inhaler. Please consult your doctor.

driving
When using Combiwave SF 25mcg/125mcg Inhaler, it is important to note that no interactions affecting driving have been established. Always follow safety precautions while driving.

pregnancy
Combiwave SF 25mcg/125mcg Inhaler may not be safe to use during pregnancy. Animal studies have indicated potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Consult your doctor for advice.

breastfeeding
It is better to consult your doctor before using Combiwave SF 25mcg/125mcg Inhaler.
Age above 75(Geriatrics)
Combiwave SF 25mcg/125mcg Inhaler should be used with caution in elderly patients. Your doctor will decide the correct dose and duration of the treatment with Combiwave SF 25mcg/125mcg Inhaler for you depending upon your age, health condition and body weight. Consult your doctor before using it.
Consumption warning before consuming Combiwave SF 25mcg/125mcg Inhaler
Before using Combiwave SF 25mcg/125mcg Inhaler, it is crucial to notify your doctor if you have any allergies to this medication or its components. If you are pregnant, breastfeeding, or have children under 12 years old, consult your doctor before using this inhaler. Some individuals may experience worsened asthma symptoms with Combiwave SF 25mcg/125mcg Inhaler 240, and in case of severe breathing difficulties, seek immediate medical attention for appropriate treatment. Inform your doctor if you notice blurred vision or any vision changes while using this medication. Regular monitoring of potassium levels is advised due to the potential for decreased potassium levels in the blood while using Combiwave SF 25mcg/125mcg Inhaler 240. Patients with specific conditions like high blood pressure, diabetes, chest or lung infections, hyperthyroidism, low potassium levels, glaucoma, cataracts, osteoporosis, tuberculosis, or heart, liver, or adrenal gland issues should inform their healthcare provider before starting this medication.
Disease interactions
Before using Combiwave SF 25mcg/125mcg Inhaler, it is essential to disclose to your doctor if you have certain medical conditions. These include high blood pressure, diabetes, chest or lung infections, an overactive thyroid (hyperthyroidism), low potassium levels in the blood (hypokalaemia), glaucoma, cataracts, weak bones (osteoporosis), tuberculosis, as well as heart, liver, or adrenal gland problems. Informing your doctor about these conditions is crucial as they may interact with Combiwave SF 25mcg/125mcg Inhaler and affect its effectiveness or potentially lead to adverse effects. By providing your healthcare provider with a comprehensive medical history, they can make informed decisions regarding the suitability of Combiwave SF 25mcg/125mcg Inhaler for your specific health needs.
What if you forgot to take Combiwave SF 25mcg/125mcg Inhaler?
If you forget to take a dose of Combiwave SF 25mcg/125mcg Inhaler, try to use it as soon as you remember. But if it's close to the time for your next dose, it's better to skip the missed one and continue with your regular dosing schedule. It's important not to take a double dose to make up for the missed one. Remember to always follow the instructions for Combiwave SF 25mcg/125mcg Inhaler to ensure you are using it correctly for your condition.
What happens if you take overdose of Combiwave SF 25mcg/125mcg Inhaler?
In the event of accidental overdose of Combiwave SF 25mcg/125mcg Inhaler, it is crucial to seek immediate medical attention. Symptoms of an overdose may include angina (a specific type of chest pain), fluctuations in blood pressure, palpitations, fast or irregular heartbeat, extended QTc interval, headache, tremors, nervousness, muscle cramps, dry mouth, insomnia, fatigue, malaise, seizures, metabolic acidosis, low potassium levels, abnormal blood sugar levels, nausea, vomiting, loss of consciousness, as well as suppression of the hypothalamic-pituitary-adrenocortical (HPA) axis function which can manifest as anorexia, poor weight gain, and growth suppression. It is important to consult a healthcare professional immediately in case of overdose of Combiwave SF 25mcg/125mcg Inhaler to prevent potential complications.
Related lab tests
When it comes to the medication Combiwave SF 25mcg/125mcg Inhaler, there are a few related lab tests that can help monitor its effectiveness and possible side effects. One important test is the Absolute Eosinophil Count, which measures the number of a specific type of white blood cell that can be elevated in conditions such as asthma and allergies. This test can provide valuable information on how well the medication is controlling inflammation in the body.
Another essential lab test is the Complete Blood Count, which gives an overall picture of the different types of blood cells in the body, including white blood cells, red blood cells, and platelets. Monitoring changes in these values can help healthcare providers assess the medication's impact on the body's immune system and overall health.
In addition to lab tests, imaging studies such as a Chest X-ray may also be necessary to evaluate the condition of the lungs and check for any signs of inflammation or infection. Pulmonary function tests are another crucial tool in assessing lung function and can help determine how well the medication is managing respiratory issues.
Related Lab Tests:
1. Absolute Eosinophil Count
2. Complete Blood Count
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹298
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024